STINGINN, LLC

Harnessing the innate immune system to combat infectious disease, inflammation, and cancer

Miami, United States · Founded 2020 · $2.4M raised

Headquarters
Miami, Florida
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$2.4M
Last Round
$400K GrantJul 2023
Rounds
2

About

StingInn LLC is a clinical-stage biotechnology company harnessing the innate immune system to combat infectious disease, inflammation, and cancer. The company's pipeline is built around the STING (stimulator of interferon genes) signaling pathway, with therapeutics including STING activators (STAVs) for anti-tumor immunotherapy, STING inhibitors for autoimmune and inflammatory disease, and an HTLV-1 vaccine. StingInn has received FDA approval to initiate Phase I clinical trials for leukemia treatment.

Summary

STINGINN, LLC is a Biotech company based in Miami, United States, founded in 2020. It has raised $2.4M in total across 2 rounds, most recently a $400K Grant round in Jul 2023. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJul 2023
$400K

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

STINGINN, LLC on Indexed.vc
<a href="https://indexed.vc/companies/stinginn-llc"><img src="https://indexed.vc/api/badge/company/stinginn-llc" alt="STINGINN, LLC on Indexed.vc" width="260" height="76" /></a>